These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24321706)

  • 1. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption.
    Kim RY; Oh JH; Lee BS; Seo YK; Hwang SJ; Kim IS
    Biomaterials; 2014 Feb; 35(6):1869-81. PubMed ID: 24321706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local administration of nuclear factor of activated T cells (NFAT) c1 inhibitor to suppress early resorption and inflammation induced by bone morphogenetic protein-2.
    Kim RY; Seong Y; Cho TH; Lee B; Kim IS; Hwang SJ
    J Biomed Mater Res A; 2018 May; 106(5):1299-1310. PubMed ID: 29316218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.
    Bougioukli S; Jain A; Sugiyama O; Tinsley BA; Tang AH; Tan MH; Adams DJ; Kostenuik PJ; Lieberman JR
    Bone; 2016 Mar; 84():93-103. PubMed ID: 26723577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model.
    Pelaez M; Susin C; Lee J; Fiorini T; Bisch FC; Dixon DR; McPherson JC; Buxton AN; Wikesjö UM
    J Clin Periodontol; 2014 Aug; 41(8):827-36. PubMed ID: 24807100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Slow-release recombinant human bone morphogenetic protein-2 suppresses chromium wear particle-induced osteolysis in rats].
    Li G; Li Q; Lin LJ; Duan X; Zhang XQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):391-5. PubMed ID: 22445991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.
    Hyun SJ; Han DK; Choi SH; Chai JK; Cho KS; Kim CK; Kim CS
    J Periodontol; 2005 Oct; 76(10):1667-74. PubMed ID: 16253088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rhBMP-2/calcium phosphate matrix induces bone formation while limiting transient bone resorption in a nonhuman primate core defect model.
    Seeherman HJ; Li XJ; Smith E; Wozney JM
    J Bone Joint Surg Am; 2012 Oct; 94(19):1765-76. PubMed ID: 23032587
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cho TH; Kim IS; Lee B; Park SN; Ko JH; Hwang SJ
    Tissue Eng Part A; 2017 Dec; 23(23-24):1343-1360. PubMed ID: 28457207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.
    Pang EK; Im SU; Kim CS; Choi SH; Chai JK; Kim CK; Han SB; Cho KS
    J Periodontol; 2004 Oct; 75(10):1364-70. PubMed ID: 15562914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient Local Bone Remodeling Effects of rhBMP-2 in an Ovine Interbody Spine Fusion Model.
    Bae HW; Patel VV; Sardar ZM; Badura JM; Pradhan BB; Seim HB; Turner AS; Toth JM
    J Bone Joint Surg Am; 2016 Dec; 98(24):2061-2070. PubMed ID: 28002369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability of recombinant human bone morphogenetic protein 2 to enhance bone healing in the presence of tobramycin: evaluation in a rat segmental defect model.
    Glatt V; Kwong FN; Park K; Parry N; Griffin D; Vrahas M; Evans CH; Harris M
    J Orthop Trauma; 2009; 23(10):693-701. PubMed ID: 19858977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2.
    Kim IS; Lee EN; Cho TH; Song YM; Hwang SJ; Oh JH; Park EK; Koo TY; Seo YK
    Tissue Eng Part A; 2011 Feb; 17(3-4):337-48. PubMed ID: 20868206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of recombinant human bone morphogenetic protein-2 and -9 on bone formation in rat calvarial critical-size defects.
    Nakamura T; Shirakata Y; Shinohara Y; Miron RJ; Hasegawa-Nakamura K; Fujioka-Kobayashi M; Noguchi K
    Clin Oral Investig; 2017 Dec; 21(9):2671-2679. PubMed ID: 28197731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment.
    Toth JM; Boden SD; Burkus JK; Badura JM; Peckham SM; McKay WF
    Spine (Phila Pa 1976); 2009 Mar; 34(6):539-50. PubMed ID: 19240666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel model of calvarial defect in an infected unfavorable wound: reconstruction with rhBMP-2. Part II.
    Kinsella CR; Cray JJ; Smith DM; Rottgers SA; Mooney MP; Cooper GM; Losee JE
    J Craniofac Surg; 2012 Mar; 23(2):410-4. PubMed ID: 22421834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of recombinant human bone morphogenetic protein-2 on residual ridge resorption after tooth extraction: an experimental study in the rat.
    Matin K; Nakamura H; Irie K; Ozawa H; Ejiri S
    Int J Oral Maxillofac Implants; 2001; 16(3):400-11. PubMed ID: 11432660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of low-level laser irradiation (LLLI) and rhBMP-2 in critical bone defect of ovariectomized rats: histomorphometric evaluation.
    Siéssere S; de Sousa LG; Issa JP; Iyomasa MM; Pitol DL; Barbosa AP; Semprini M; Sebald W; Bentley MV; Regalo SC
    Photomed Laser Surg; 2011 Jul; 29(7):453-8. PubMed ID: 21303263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
    Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
    J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
    Koyama H; Nakade O; Takada Y; Kaku T; Lau KH
    J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.